366
Z.-Q. Tang, Y. Chen, C.-N. Liu, K.-Y. Cai, and S.-J. Tu
Vol 47
(d, 2H, CH2, J ¼ 16.0 Hz), 1.77 (d, 2H, CH2, J ¼ 16.0 Hz),
0.89 (s, 6H, CH3), 0.72 (s, 6H, CH3). Anal calcd. for
C29H29Cl2NO2: C, 70.44; H, 5.91; N, 2.83. Found: C, 70.21;
H, 6.02; N, 2.71.
9-(4-Fluorophenyl)-10-(4-tolyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-
hexahydroacridine1,8-[2H,5H]-dione (4n). mp 267–269ꢀC. (lit.
mp: 262–294ꢀC) [17]. This compound was obtained according
to earlier general procedure. IR (potassium bromide): 3063,
2931, 2870, 1651, 1575, 1508, 1451, 1142, 1000, 843. 1H
NMR: 7.41 (d, 2H, ArH, J ¼ 7.6 Hz), 7.30–7.34 (m, 4H,
ArH), 7.04–7.08 (m, 2H, ArH), 5.03 (s, 1H, CH), 2.42 (s, 3H,
CH3), 2.20–2.22 (m, 4H, 2CH2), 2.00 (d, 2H, CH2, J ¼ 16.0
Hz), 1.77 (d, 2H, CH2, J ¼ 17.6 Hz), 0.88 (s, 6H, CH3), 0.71
(s, 6H, CH3). Anal calcd. for C30H32FNO2: C, 78.75; H, 7.05;
N, 3.06. Found: C, 78.94; H, 7.18; N, 3.02.
9-(4-Bromophenyl)-10-(4-chlorophenyl)-3,3,6,6-tetramethyl-
3,4,6,7,9,10-hexahydroacridine-1,8-[2H,5H]-dione (4i). mp:
254–256ꢀC. (lit. mp: 249–251ꢀC) [20]. This compound was
obtained according to earlier general procedure. IR (potassium
bromide): 2958, 2869, 1639, 1578, 1577, 1491, 1361, 1221,
1145, 1089, 1009, 839. 1H NMR: 7.68 (d, 2H, ArH, J ¼ 8.0
Hz), 7.42–7.48 (m, 4H, ArH), 7.26 (d, 2H, ArH, J ¼ 8.0 Hz),
4.99 (s, 1H, CH), 2.17–2.23 (m, 4H, 2CH2), 2.01 (d, 2H, CH2,
J ¼ 16.0 Hz), 1.76 (d, 2H, CH2, J ¼ 16.0 Hz), 0.89 (s, 6H,
CH3), 0.72 (s, 6H, CH3). Anal calcd. for C29H29BrClNO2: C,
64.63; H, 5.42; N, 2.60. Found: C, 64.81; H, 5.28; N, 2.68.
9-(4-Nitrophenyl)-10-(4-chlorophenyl)-3,3,6,6-tetra methyl-
3,4,6,7,9,10-hexahydroacridine-1,8-[2H,5H]-dione (4j). mp
>300ꢀC. This compound was obtained according to earlier
general procedure. IR (potassium bromide): 2959, 2870, 1638,
1577, 1491, 1361, 1342, 1222, 1145, 1089, 1009, 831. 1H
NMR: 7.67–7.70 (m, 2H, ArH), 7.48–7.50 (m, 2H, ArH),
7.28–7.33 (m, 4H, ArH), 5.01 (s, 1H, CH), 2.17–2.22 (m, 4H,
2CH2), 2.02 (d, 2H, CH2, J ¼ 16.0 Hz), 1.77 (d, 2H, CH2, J
¼ 16.0 Hz), 0.89 (s, 6H, CH3), 0.72 (s, 6H, CH3). Anal calcd.
for C29H29ClN2O4: C, 68.97; H, 5.79; N, 5.55. Found: C,
69.14; H, 5.61; N, 5.42.
9-(Benzo[d][1,3]dioxo-5-yl)-10-(4-chlorophenyl)-3,3, 6,6-tetra-
methyl-3,4,6,7,9,10-hexahydroacridine-1,8-[2H,5H]-dione
(4k). mp 287–288ꢀC. (lit. mp: 287–288ꢀC) [24]. This com-
pound was obtained according to earlier general procedure. IR
(potassium bromide): 2955, 2871, 1641, 1578, 1490, 1360,
1254, 1221, 1141, 1042, 921, 813. 1H NMR: 7.68 (d, 2H,
ArH, J ¼ 8.8 Hz), 7.42–7.45 (m, 2H, ArH), 6.77–6.79 (m, 3H,
ArH), 5.94 (s, 2H, CH2), 4.96 (s, 1H, CH), 2.16–2.20 (m, 4H,
2CH2), 2.03 (d, 2H, CH2, J ¼ 17.6 Hz), 1.78 (d, 2H, CH2, J
¼ 17.2 Hz), 0.89 (s, 6H, CH3), 0.75 (s, 6H, CH3). Anal calcd.
for C30H30ClNO4: C, 71.49; H, 6.00; N, 2.78. Found: C,
71.23; H, 6.18; N, 2.69.
9-(Benzo[d][1,3]dioxo-5-yl)-10-(4-tolyl)-3,4,6,7,9,10-hexahy-
droacridine-1,8-[2H,5H]-dione (4o). mp 236–238ꢀC. This com-
pound was obtained according to earlier general procedure. IR
(potassium bromide): 3031, 2945, 2888, 1642, 1570, 1486, 1362,
1
1285, 1231, 1135, 1040, 857, 799. H NMR: 7.37 (d, 3H, ArH,
J ¼ 8.0 Hz), 7.16–7.18 (m, 1H, ArH), 6.72–6.79 (m, 3H, ArH),
5.94 (s, 2H, CH2), 5.06 (s, 1H, CH), 2.97 (s, 3H, CH3), 2.18–
2.24 (m, 6H, 3CH2), 1.91–1.96 (m, 2H, CH2), 1.76–1.84 (m, 2H,
CH2), 1.59–1.65 (m, 2H, CH2). Anal calcd. for C27H25NO4: C,
75.86; H, 5.89; N, 3.28. Found: 75.81; H, 6.01; N, 3.41.
9-(4-Fluorophenyl)-10-(p-tolyl)-3,4,6,7,9,10-hexahy-droacri-
dine-1,8-[2H,5H]-dione (4p). mp 263–264ꢀC. This compound
was obtained according to earlier general procedure. IR (potas-
sium bromide): 3059, 2929, 2870, 1633, 1571, 1507, 1360,
1284, 1231, 1134, 839. 1H NMR: 7.37–7.39 (m, 3H, ArH),
7.19–7.31 (m, 3H, ArH), 7.02–7.07 (m, 2H, ArH), 5.13 (s, 1H,
CH), 2.40 (s, 3H, CH3), 2.18–2.22 (m, 6H, 3CH2), 1.92–1.97
(m, 2H, CH2), 1.79–1.84 (m, 2H, CH2), 1.63–1.65 (m, 2H,
CH2). Anal calcd. for C26H24FNO2: C, 77.78; H, 6.03; N,
3.49. Found: C, 77.94; H, 5.85; N, 3.31.
9-(4-Bromophenyl)-10-(p-tolyl)-3,4,6,7,9,10-hexahy-droacri-
dine-1,8-[2H,5H]-dione (4q). mp >300ꢀC. (lit. mp: > 300ꢀC)
[17]. This compound was obtained according to earlier general
procedure. IR (potassium bromide): 3040, 2923, 2867, 1644,
1572, 1510, 1485, 1361, 1283, 1230, 1134, 1069, 831. 1H
NMR: 7.37–7.43 (m, 5H, ArH), 7.24 (d, 2H, ArH, J ¼ 8.4
Hz), 7.14 (d, 1H, ArH, J ¼ 8.4 Hz), 5.10 (s, 1H, CH), 2.40 (s,
3H, CH3), 2.18–2.21 (m, 8H, 4CH2), 1.92–1.97 (m, 2H, CH2),
1.77–1.85 (m, 2H, CH2). Anal calcd. for C26H24BrNO2: C,
67.54; H, 5.23; N, 3.03. Found: C, 67.72; H, 5.06; N, 3.19.
9-(4-Nitrophenyl)-10-(p-tolyl)-3,4,6,7,9,10-hexahy-droacridine-
1,8-[2H,5H]-dione (4r). mp >300ꢀC. (lit. mp: > 300ꢀC) [17].
This compound was obtained according to earlier general pro-
cedure. IR (potassium bromide): 2953, 2915, 1631, 1600,
1574, 1511, 1342, 1284, 1230, 1179, 1132. 1H NMR: 7.31–
8.13 (m, 8H, ArH), 5.23 (s, 1H, CH), 2.40 (s, 3H, CH3), 1.94–
2.89 (m, 8H, 4CH2), 1.79–1.85 (m, 2H, CH2), 1.62–1.65 (m,
2H, CH2). Anal calcd. for C26H24N2O4: C, 72.88; H, 5.65; N,
6.54. Found: C, 72.72; H, 5.84; N, 6.70.
9-(4-Methoxyphenyl)-10-(4-chlorophenyl)-3,3,6,6-tetramethyl-
3,4,6,7,9,10-hexahydroacridine1,8-[2H,5H]-dione (4l). mp 269–
270ꢀC. (lit. mp: 269–271ꢀC) [27]. This compound was
obtained according to earlier general procedure. IR (potassium
bromide): 2952, 1641, 1578, 1491, 1361, 1259, 1173, 1140,
998, 834, 740. 1H NMR: 7.68 (d, 2H, ArH, J ¼ 8.0), 7.44–
7.47 (m, 2H, ArH ), 7.21 (d, 2H, ArH, J ¼ 8.0 Hz), 6.80 (d,
2H, ArH, J ¼ 8.0 Hz), 4.97 (s, 1H, CH), 3.69 (s, 3H, OCH3),
2.16–2.22 (m, 4H, 2CH2), 2.00 (d, 2H, CH2, J ¼ 16.0 Hz),
1.77 (d, 2H, CH2, J ¼ 17.6 Hz), 0.89 (s, 6H, CH3), 0.73 (s,
6H, CH3). Anal calcd. for C30H32ClNO3: C, 73.53; H, 6.58; N,
2.86. Found: C, 73.73; H, 6.62; N, 2.71.
9-(4-Bromophenyl)-10-phenyl-3,3,6,6-tetramethyl-3,4,6,7,9,10-
hexahydroacridine-1,8-[2H,5H]-dione (4m). mp 285–287ꢀC.
(lit. mp: > 300ꢀC) [20]. This compound was obtained accord-
ing to earlier general procedure. IR (potassium bromide):
3060, 2956, 2869, 1639, 1577, 1491, 1452, 1361, 1261, 1176,
1008, 838. 1H NMR: 7.55–7.64 (m, 3H, ArH), 7.45 (d, 4H,
ArH, J ¼ 8.0 Hz), 7.27 (d, 2H, ArH, J ¼ 8.0 Hz), 5.01 (s, 1H,
CH), 2.18–2.23 (m, 4H, 2CH2), 2.01 (d, 2H, CH2, J ¼ 16.0
Hz), 1.75 (d, 2H, CH2, J ¼ 16.0 Hz), 0.87 (s, 6H, CH3), 0.71
(s, 6H, CH3). Anal calcd. for C29H30BrNO2: C, 69.05; H, 5.99;
N, 2.78. Found: 69.18; H, 5.76; N, 2.54.
9-(4-Methoxyphenyl)-10-(p-tolyl)-3,4,6,7,9,10-hexahydroacridine-
1,8-[2H,5H]-dione (4s). mp 241.2–243.0ꢀC. (lit. mp: 256–
257ꢀC) [17]. This compound was obtained according to earlier
general procedure. IR (potassium bromide): 2938, 1637, 1569,
1509, 1360, 1287, 1232, 1181, 1130, 954, 913, 825, 758. 1H
NMR: 7.37–7.86 (m, 4H, ArH), 7.18 (d, 2H, ArH, J ¼ 8.8
Hz), 6.80 (d, 2H, ArH, J ¼ 8.4 Hz), 5.07 (s, 1H, CH), 3.70 (s,
3H, OCH3), 2.40 (s, 3H, CH3), 2.18–2.25 (m, 6H, 3CH2),
1.80–1.83 (m, 4H, 2CH2), 1.59–1.61 (m, 2H, CH2). Anal
calcd. for C27H27NO3: C, 78.42; H, 6.58; N, 3.39. Found: C,
78.69; H, 6.72; N, 3.12.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet